Please log in to view this page
Username
Password
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
